EMA – Meeting Highlights From the Pharmacovigilance Risk Assessment …
EMA – Meeting highlights from the Pharmacovigilance Risk Assessment …
The affected medicines (called RAS-acting agents) are used particularly in the treatment of hypertension (high blood pressure) and congestive heart failure (a type of heart disease where the heart cannot pump enough blood around the body). The PRAC …
Read more on DeHavilland (press release) (subscription)
Find More Methadone Treatment Uk Information…